ТОО "АЛЬТАИР МЕДИКУС"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
0/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
41201 Строительство жилых зданий
Строительство жилых зданий
Contacts
Change history
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
2- АД
Ахметова Динара Касымовна
Director
Former directors
- КРКАЛИЕВА РАУЗА ДОСЖАНОВНА
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "АЛЬТАИР МЕДИКУС" (BIN 061040000835): Active legal entity, Almaty, registered in 2006, 20 years on the market. Main activity: construction of buildings. Small enterprise, headcount: up to 5 employees. No risk indicators for «АЛЬТАИР МЕДИКУС» were found in open registries. The latest change to registration data: change of address (December 1, 2021). Number of founders: 1. Head per the registry: Ахметова Динара Касымовна. Per the registry as of June 11, 2026.
Data sources and disclaimer
Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.